Ken Griffin Nano Vibronix, Inc. Transaction History

Citadel Advisors LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.25 - $9.02 $14,038 - $506,491	56,152 New	56,152 $14,000
Q2 2022 Aug 15, 2022	SELL	$0.55 - $1.19 $71,756 - $155,254	-130,466 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$0.7 - $1.16 $62,749 - $103,984	89,642 Added 219.58%	130,466 $151,000
Q3 2021 Nov 15, 2021	SELL	$0.7 - $3.37 $41,316 - $198,910	-59,024 Reduced 59.11%	40,824 $84,000
Q2 2021 Aug 16, 2021	SELL	$0.79 - $1.15 $29,816 - $43,403	-37,742 Reduced 27.43%	99,848 $84,000
Q1 2021 May 17, 2021	BUY	$0.83 - $1.51 $114,199 - $207,760	137,590 New	137,590 $139,000
Q4 2020 Feb 16, 2021	SELL	$0.56 - $1.13 $12,457 - $25,136	-22,245 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$0.59 - $2.24 $13,124 - $49,828	22,245 New	22,245 $16,000
Q1 2020 May 15, 2020	SELL	$1.95 - $2.9 $25,777 - $38,335	-13,219 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$2.5 - $3.08 $33,047 - $40,714	13,219 New	13,219 $38,000
Q2 2019 Aug 14, 2019	SELL	$2.77 - $4.5 $40,671 - $66,073	-14,683 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$3.21 - $4.34 $47,132 - $63,724	14,683 New	14,683 $0

Ticker NAOV
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 27,997,800
Market Cap $16.2M
Description
NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its principal products include UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary ca...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.